Robert J Morrison1,2, Nicolas-George Katsantonis1, Kevin M Motz3, Alexander T Hillel3, C Gaelyn Garrett1, James L Netterville1, Christopher T Wootten1, Susan M Majka4, Timothy S Blackwell4,5, Wonder P Drake6, Alexander Gelbard1. 1. 1 Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University, Nashville, Tennessee, USA. 2. 2 Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA. 3. 3 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins, Baltimore, Maryland, USA. 4. 4 Department of Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, Tennessee, USA. 5. 5 Veterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA. 6. 6 Division of Infectious Disease, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Abstract
OBJECTIVE: To characterize the phenotype and function of fibroblasts derived from airway scar in idiopathic subglottic stenosis (iSGS) and to explore scar fibroblast response to interleukin 17A (IL-17A). STUDY DESIGN: Basic science. SETTING: Laboratory. SUBJECTS AND METHODS: Primary fibroblast cell lines from iSGS subjects, idiopathic pulmonary fibrosis subjects, and normal control airways were utilized for analysis. Protein, molecular, and flow cytometric techniques were applied in vitro to assess the phenotype and functional response of disease fibroblasts to IL-17A. RESULTS: Mechanistically, IL-17A drives iSGS scar fibroblast proliferation ( P < .01), synergizes with transforming growth factor ß1 to promote extracellular matrix production (collagen and fibronectin; P = .04), and directly stimulates scar fibroblasts to produce chemokines (chemokine ligand 2) and cytokines (IL-6 and granulocyte-macrophage colony-stimulating factor) critical to the recruitment and differentiation of myeloid cells ( P < .01). Glucocorticoids abrogated IL-17A-dependent iSGS scar fibroblast production of granulocyte-macrophage colony-stimulating factor ( P = .02). CONCLUSION: IL-17A directly drives iSGS scar fibroblast proliferation, synergizes with transforming growth factor ß1 to promote extracellular matrix production, and amplifies local inflammatory signaling. Glucocorticoids appear to partially abrogate fibroblast-dependent inflammatory signaling. These results offer mechanistic support for future translational study of clinical reagents for manipulation of the IL-17A pathway in iSGS patients.
OBJECTIVE: To characterize the phenotype and function of fibroblasts derived from airway scar in idiopathic subglottic stenosis (iSGS) and to explore scar fibroblast response to interleukin 17A (IL-17A). STUDY DESIGN: Basic science. SETTING: Laboratory. SUBJECTS AND METHODS: Primary fibroblast cell lines from iSGS subjects, idiopathic pulmonary fibrosis subjects, and normal control airways were utilized for analysis. Protein, molecular, and flow cytometric techniques were applied in vitro to assess the phenotype and functional response of disease fibroblasts to IL-17A. RESULTS: Mechanistically, IL-17A drives iSGS scar fibroblast proliferation ( P < .01), synergizes with transforming growth factor ß1 to promote extracellular matrix production (collagen and fibronectin; P = .04), and directly stimulates scar fibroblasts to produce chemokines (chemokine ligand 2) and cytokines (IL-6 and granulocyte-macrophage colony-stimulating factor) critical to the recruitment and differentiation of myeloid cells ( P < .01). Glucocorticoids abrogated IL-17A-dependent iSGS scar fibroblast production of granulocyte-macrophage colony-stimulating factor ( P = .02). CONCLUSION:IL-17A directly drives iSGS scar fibroblast proliferation, synergizes with transforming growth factor ß1 to promote extracellular matrix production, and amplifies local inflammatory signaling. Glucocorticoids appear to partially abrogate fibroblast-dependent inflammatory signaling. These results offer mechanistic support for future translational study of clinical reagents for manipulation of the IL-17A pathway in iSGS patients.
Authors: Daryan R Namba; Garret Ma; Idris Samad; Dacheng Ding; Vinciya Pandian; Jonathan D Powell; Maureen R Horton; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2015-03-09 Impact factor: 3.497
Authors: Vrajesh V Parekh; Lan Wu; Kelli L Boyd; Janice A Williams; Jennifer A Gaddy; Danyvid Olivares-Villagómez; Timothy L Cover; Wei-Xing Zong; Jianhua Zhang; Luc Van Kaer Journal: J Immunol Date: 2013-04-17 Impact factor: 5.422
Authors: Fabien Maldonado; Andrea Loiselle; Zachary S Depew; Eric S Edell; Dale C Ekbom; Michael Malinchoc; Clinton E Hagen; Eran Alon; Jan L Kasperbauer Journal: Laryngoscope Date: 2013-08-08 Impact factor: 3.325
Authors: Alexander Gelbard; Nicolas-George Katsantonis; Masanobu Mizuta; Dawn Newcomb; Joseph Rotsinger; Bernard Rousseau; James J Daniero; Eric S Edell; Dale C Ekbom; Jan L Kasperbauer; Alexander T Hillel; Liying Yang; C Gaelyn Garrett; James L Netterville; Christopher T Wootten; David O Francis; Charles Stratton; Kevin Jenkins; Tracy L McGregor; Jennifer A Gaddy; Timothy S Blackwell; Wonder P Drake Journal: Laryngoscope Date: 2016-06-14 Impact factor: 3.325
Authors: Alexander Gelbard; Nicolas-George Katsantonis; Masanobu Mizuta; Dawn Newcomb; Joseph Rotsinger; Bernard Rousseau; James J Daniero; Eric S Edell; Dale C Ekbom; Jan L Kasperbauer; Alexander T Hillel; Liying Yang; C Gaelyn Garrett; James L Netterville; Christopher T Wootten; David O Francis; Charles Stratton; Kevin Jenkins; Tracy L McGregor; Jennifer A Gaddy; Timothy S Blackwell; Wonder P Drake Journal: Laryngoscope Date: 2016-06-14 Impact factor: 3.325
Authors: Ruth J Davis; Ioan Lina; Dacheng Ding; Elizabeth L Engle; Janis Taube; Alexander Gelbard; Alexander T Hillel Journal: Laryngoscope Date: 2020-06-17 Impact factor: 3.325
Authors: Stephen S Schoeff; Xudong Shi; William G Young; Chad W Whited; Resha S Soni; Peng Liu; Irene M Ong; Seth H Dailey; Nathan V Welham Journal: Laryngoscope Date: 2020-07-03 Impact factor: 3.325
Authors: Ruth J Davis; Ioan Lina; Benjamin Green; Elizabeth L Engle; Kevin Motz; Dacheng Ding; Janis M Taube; Alexander Gelbard; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2020-12-08 Impact factor: 5.591
Authors: Ruth J Davis; Ioan Lina; Kevin Motz; Alexander Gelbard; Robert R Lorenz; Guri S Sandhu; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2021-07-13 Impact factor: 5.591